Products & ReviewLife Sciences

RapiDxFire™ Lyo-Flex 1-Step RT-qPCR 5X Master Mix

Designed with input from top molecular diagnostic assay manufacturers, the RapiDxFire Lyo-Flex 1-Step RT-qPCR 5x Master Mix supports the development of diagnostic devices and assays that meet healthcare provider and consumer demand for fast, accurate results. With consistent results in a liquid state at room temp or in a lyophilised state, this master mix will help you achieve predictable performance in unpredictable conditio…

Buy Now
LGC Biosearch Technologies

Place your order directly with the manufacturer.

Ease of Use
After Sales Service
Value for Money
Be the first to leave a review
Description

RapiDxFire Lyo-Flex stands out from competitor mixes with an ideal combination of features and benefits.

  • The unique heat-activated thermostable reverse transcriptase can withstand cDNA synthesis at high temperatures, enabling the detection of previously elusive viruses.
  • 5x concentration creates an opportunity for higher test sensitivity while reducing waste.
  • The master mix can detect RNA and DNA templates, making it ideal for viruses as well as bacteria.
  • With an abundance of key PCR reaction components, this master mix supports the detection of multiple pathogens in a single reaction.
  • The master mix remains stable in a broad range of temperatures and conditions, giving you more flexibility in shipping, storage, and automation setup.
  • Lyophilize this master mix and bring PCR-based pathogen detection out of the lab.
Application eBookClinical Diagnostics

Simplifying the journey from molecular diagnostic assay development to commercialization

Molecular diagnostics (MDx) is rapidly advancing, with a growing array of DNA- and RNA-based tests now available to physicians, pharmacists, geneticists, research scientists, and other healthcare professionals.

As labs work with human and microbial genes, test developers must comply with clinical guidelines and regulations. Both established companies and start-ups face challenges, including meeting regulatory standards, ensuring quality, and managing supply chain issues. Early planning and robust partnerships are key to overcoming these obstacles.

This essential guide explores these challenges through detailed case studies. It covers everything from early development and assay formulation, to supply chain security, offering expert insights on successfully bringing PCR, next-generation sequencing (NGS), and other nucleic acid-based diagnostic tests to market.


Application NoteLife Sciences

RapiDxFire Lyo-Flex 1-Step RT-qPCR 5X Master Mix

LGC demonstrates the analytical sensitivity and specificity of the RapiDxFire Lyo-Flex 1-Step RT-qPCR 5X Master Mix for both RNA and DNA genomes, its effectiveness at single-tube multiplexing in an MDx scenario, and the stability of the reaction components under various storage and handling conditions.


The future of diagnostics: How innovators in molecular techniques are shaping healthcare

From enzymatics to informatics, Hillary Sullivan, Vice President of R&D at LGC Biosearch Technologies, shares her thoughts on some of the latest advancements in molecular diagnostics. With insights from successful partnerships in healthcare, Sullivan provides her perspective on what the most promising areas of scientific advancements might hold for this rapidly developing field in the next 25 years.

Product Overview

Links

Buy RapiDxFire™ Lyo-Flex 1-Step RT-qPCR 5X Master Mix Read Reviews